New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
07:37 EDTTHORThoratec price target raised to $39 from $37 at Canaccord
Canaccord raised its price target on Thoratec to $39 from $37 following the company's proposed acquisition of Apica. The firm sees double digit earnings potential for Thoratec given its VAD prospects and ability to target the fast growing acute MCS space and keeps its Buy rating on the stock.
News For THOR From The Last 14 Days
Check below for free stories on THOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
07:21 EDTTHORHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 9, 2014
16:46 EDTTHORThoratec announces start of Heartmate III U.S. clinical trial
Subscribe for More Information
September 4, 2014
10:01 EDTTHORThoratec management to meet with Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use